New antibiotics are needed as resistance grows, expert saysBMJ 2008; 337 doi: http://dx.doi.org/10.1136/bmj.a1660 (Published 12 September 2008) Cite this as: BMJ 2008;337:a1660
- Philip Wilson
Drug regulators should ensure that unnecessary hurdles don’t prevent the licensing of new antibiotics, a leading expert in treating resistant infections has said. David Livermore, director of the UK Health Protection Agency’s antimicrobial resistance monitoring unit, also called on drug companies not to abandon research into an area sometimes seen as unprofitable.
“Antibiotics are a precious resource in fighting infections, and one that we must do everything we can to preserve,” he said at a press conference on 10 September. “That is why we need to ensure there is a constant range of options under development.”
Public concern over resistance to antibiotics has centred on meticillin resistant …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial